Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Dexcom (DXCM)

Dexcom Adds Google's Rick Osterloh to Board, Expands Board to Twelve Directors

Neutral Impact 2 of 5 leadership Written later

Dexcom's board increased its size to twelve directors and appointed Albert F. ("Rick") Osterloh IV, Senior Vice President, Platforms & Devices at Google, as a director effective February 26, 2026. He joins the Compensation and Technology Committees, and the filing describes him as independent under Nasdaq listing standards.

Key points

  • Osterloh's term expires at the 2026 annual stockholder meeting.
  • Initial equity grant of restricted stock units with a fair value of $500,000, vesting annually over three years.
  • Expected annual director equity grant of restricted stock units with a fair value of $101,027, prorated from a $325,000 base award.

The filing

CompanyDexcom (DXCM)
Form8-K, current report
Filed with the SECFeb 26, 2026, 4:15 PM ET
Accession number0001093557-26-000031

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 26, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.